Browse All
Displaying 1 - 1 of 1
Author:Bar-Or, Amit Oh, Jiwon Giovannoni, Gavin Sormani, Maria Pia Weber, Martin S. Stoll, Sharon Nicholas, Jacqueline A. Büdingen, H.-Christian von Lopez, Jon Roberts, Louise Triyatni, Miriam Qi, Qi Ratchford, John N. Napieralski, Julie Goodyear, Alexandra Hauser, Stephen L. Kappos, Ludwig
Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence
Topic:Multiple Sclerosis
Program Number:S40.004
Author Institution:Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA St. Michael’s Hospital, University of Toronto, Toronto, ON, Canada, Toronto, ON, Canada Queen Mary University of London, London, UK, London, United Kingdom University of Genoa, Genoa, Italy, Genoa, Italy Institute of Neuropathology and Department of Neurology, University Medical Center and Fraunhofer Institute for Translational Medicine and Pharmacology, Göttingen, Germany, Göttingen, Germany Advocare Stoll Medical Group, Philadelphia, PA, USA, Philadelphia, PA OhioHealth Multiple Sclerosis Centre, Riverside Methodist Hospital, Columbus, OH, USA, Columbus, OH F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland Genentech, Inc., South San Francisco, CA, USA, South San Francisco, CA University of California San Francisco, San Francisco, CA, USA, San Francisco, CA University Hospital and University Basel, Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Basel, Switzerland, Basel, Switzerland
